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Abstract
Background: Many cases of cardiac masses have been reported in the literature, but in this case report we
described a rare case of biatrial cardiac mass that represented a challenge for diagnosis and therapy. The
differentiation between cardiac masses such as thrombi, vegetations, myxomas and other tumors is not always
straightforward and an exact diagnosis is important because of its distinct treatment strategy. Transthoracic/
esophageal echocardiography and cardiac magnetic resonance play an important role in establishing the diagnosis
of cardiac masses. However, no current noninvasive diagnostic tool has the ability to absolutely diagnose cardiac
masses; obtaining a pathological specimen by surgical resection of cardiac masses is the only reliable method to
diagnose cardiac masses accurately. Our case report is an exception in that the final diagnosis was affirmed by
empirical anticoagulation therapy based on clinical judgment and noninvasive characterization of biatrial mass.
Case presentation: We described a 54-year-old Malay man with severe mitral stenosis and atrial fibrillation who
presented with a biatrial mass. Transthoracic/esophageal echocardiography and cardiac magnetic resonance
detected a large, homogeneous right atrial mass typical of a thrombus, and a left atrial mass adhering to interatrial
septum that mimicked atrial myxoma. The risk factors, morphology, location, and characteristics of the biatrial
cardiac mass indicated a diagnosis of thrombi. However, our patient declined surgery. As a result, the nature of his
cardiac masses was not specified by histology. Of note, his left atrial mass was completely regressed by long-term
warfarin, leaving a residual right atrial mass. Thus, we affirmed the most probable diagnosis of cardiac thrombi.
During the course of treatment, he had an episode of non-fatal ischemic stroke most probably because of a
thromboembolism.
Conclusions: Noninvasive characterization of cardiac mass is essential in clarifying the diagnosis and directing
treatment strategy. Anticoagulation is a feasible treatment when the clinical assessment, risk factors, and imaging
findings indicate a diagnosis of thrombi. After prolonged anticoagulation therapy, complete resolution of biatrial
thrombi was achievable in our case.
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Background
The differentiation between cardiac masses such as
thrombi, vegetation, myxomas, and other tumors is not
always straightforward and an exact diagnosis is import-
ant because of its distinct treatment strategy [1]. Trans-
thoracic echocardiography (TTE) and transesophageal
echocardiography (TEE) play an important role in estab-
lishing a diagnosis of cardiac masses [2]. Cardiac mag-
netic resonance (CMR) offers potential advantages and
is complementary to echocardiography in the evaluation
of cardiac masses [3, 4]. However, no current noninva-
sive diagnostic tool has the ability to absolutely diagnose
cardiac masses; obtaining the pathological specimen by
surgical resection of cardiac masses is the only reliable
method to diagnose cardiac masses accurately [5–7].
Case presentation
In January 2011, a 54-year-old Malay man was referred
to our hospital for evaluation of palpitation. On examin-
ation, his pulse rate was 85/minute with irregular
rhythm and his blood pressure was 120/80 mmHg. He
was afebrile. A loud first heart sound and a soft mid-
diastolic rumbling murmur (grade 2/6 degrees) were
auscultated at mitral area with no signs of heart failure.
Electrocardiography revealed atrial fibrillation (AF). The
laboratory results showed normal hemoglobin, white
cells, and platelet counts. Renal test, liver function test,
and other laboratory test results were unremarkable. His
urine analysis was also normal.
TTE and TEE revealed severe mitral stenosis (MS).
His mitral valve was thickened and moderately calcified,
and his anterior mitral valve leaflet was “dooming” dur-
ing diastole suggestive of rheumatic origin. His mitral
valve area, which was estimated by two-dimensional
planimetry and pressure half-time method, was 0.92 cm2
and 0.91 cm2, respectively. His peak and mean mitral
valve gradients were 14 and 9 mmHg, respectively. His
left atrium (LA) and right atrium (RA) were dilated. In
his RA, we found a large, mobile, homogeneous round
mass measuring 40×35 mm. A large LA mass with simi-
lar echogenicity to his RA mass was found adhering to
interatrial septum and protruding into the left ventricle
with cardiac motion (Fig. 1). We could not identify any
stalk attached to the LA mass by TTE and TEE exami-
nations. In addition, there were no identifiable masses in
the left atrial appendage. Spontaneous echocardiographic
contrast (SEC) was observed in his LA and left ventricle.
Mild tricuspid regurgitation and mild pulmonary hyper-
tension were identified with a peak pulmonary systolic
pressure of 26 mmHg (estimation based on a peak tricus-
pid regurgitation jet velocity of 210 cm/second and an es-
timated right atrial pressure of 5 mmHg). His inferior
vena cava was not dilated and collapsible with respiration,
and there was no thrombus. His ejection fraction was esti-
mated as 45 %.
Patients with severe MS and AF are at high risk of de-
veloping intracardiac thrombi. Based on the findings by
TTE, TEE, and the presence of risk factors (AF), his RA
mass was likely to be a thrombus as described earlier.
Similar features were found in LA mass and it was
thought to be a thrombus as well. However, the charac-
teristic of LA mass adhering to atrial septum mimics
atrial myxoma, which is the most common benign car-
diac tumor [1]. The shape, mobility, and location of the
LA mass made it difficult to rule out atrial myxoma with
absolute certainty. Therefore, our patient underwent
CMR for additional noninvasive characterization of the
biatrial mass. CMR showed a giant right atrial mass meas-
uring 5.3×3.2×3.9 cm and a large left atrial lesion measur-
ing 5.0×2.4×5.1 cm adhering to interatrial septum (Fig. 2).
Both lesions were intermediate in signal on cine CMR,
and not enhanced during early and delayed enhancement
CMR. The morphology, location, and avascular character-
istics made thrombi the most likely diagnosis. The CMR
result was in agreement with TTE and TEE findings.
Based on his history, physical examinations and im-
aging findings, we recommended thrombectomy and mi-
tral valve replacement. Despite medical advice, our
patient declined surgery. We empirically initiated hep-
arin and warfarin administered intravenously to prevent
thromboembolism. His international normalized ratio
(INR) was targeted at 2.5 to 3.5. Bisoprolol was pre-
scribed for AF rate control. However, his clinical course
was complicated by his non-adherence to warfarin. His
INR was subtherapeutic (median=1.8). After 2 years of
warfarin (partial compliance), serial TTE showed no re-
gression of LA and RA masses. After 3 years of unevent-
ful follow-up, he experienced an episode of transient
ischemic attack in February 2014. Subsequently, in
December 2014, he had an episode of non-fatal ischemic
stroke manifested by right hemiparesis (motor power re-
duced to 3/5) most probably because of thromboembol-
ism. We counseled him with regard to the danger of the
thromboembolism and re-emphasized the need for treat-
ment compliance. Fortunately, he resumed warfarin and
did not demonstrate further thromboembolic events. In
March 2016 (5 years after the detection of biatrial masses), a
follow-up TTE documented complete regression of the LA
mass and a near-complete resolution of the RAmass (Fig. 3).
Thus, the most probable diagnosis of cardiac thrombi was
affirmed. He remains well on medical treatment.
Discussion
Many cases of cardiac masses have been reported in the lit-
erature, but in this case report we described a rare case of
biatrial cardiac mass that represented a challenge for diag-
nosis and therapy. In our patient, the characteristic of a left
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atrial mass adhering to the atrial septum posed a diagnos-
tic challenge in differentiating between thrombus and
myxoma, the most commonly reported cardiac masses.
The following discussion will review cases of biatrial
masses in patients with MS reported between 2008 and
2016 (Table 1). First, a 40-year-old woman with rheumatic
MS was found to have biatrial thrombi mimicking myx-
oma, and she underwent a successful thrombectomy and
valve replacement [8]. Second, a 77-year-old man with AF,
severe MS and heart failure presented with dyspnea. TEE
and TTE revealed biatrial thrombi confirmed by patho-
logical examination following thrombectomy and mitral
valve replacement [9]. Third, a 58-year-old woman pre-
sented with acute limb ischemia; she was found to have
mobile biatrial thrombi, AF, and MS and underwent
successful embolectomy, thrombectomy, and mitral valve
replacement [10]. The features of biatrial thrombi, MS,
and AF were common to all three patients. In addition, a
case of biatrial myxoma with mild MS presented with
cerebral ischemia was successfully treated with thrombo-
lytic therapy administered intravenously and surgical re-
section [11]. However, numerous cases of cardiac mass
with or without mitral valve disease with diagnostic diffi-
culties have been reported earlier. Overall, cardiac thrombi
were frequently reported [5, 7, 10, 12, 13]. In some in-
stances a cardiac thrombi mimicked atrial myxoma [5, 7].
By contrast, atrial myxoma can simulate thrombus in the
setting of MS [14]. Of interest, a thrombus could form on
top of a myxoma. In one case report of a patient with MS,










Fig. 2 Cardiac magnetic resonance. Cine four chamber view: “white blood” gradient echo (a) and “black blood” imaging (b) on early gadolinium
images showed a low signal floating lesion in the right atrium and a left atrial lesion adhering to the interatrial septum (white triangles). LA left
















Fig. 1 Images obtained by transthoracic echocardiography and transesophageal echocardiography. a, b Transthoracic echocardiography images.
c, d Transesophageal echocardiography images. A large left atrial mass (arrows) adhering to interatrial septum in parasternal long axis (a) and
apical four chamber view (b, d) and a giant right atrial mass (notched arrows) was seen in apical four chamber (b) and bicaval view (c). LA left
atrium, LV left ventricle, RA right atrium, RV right ventricle
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characterized by echocardiography and CMR. However,
histopathological evaluation of the left atrial mass
removed during surgery revealed a massive thrombus
formed on top of a very small pre-existing left atrial
myxoma [12]. To complicate matters further, atrial
thrombus may have a stalk [6] or neovascularization [13]
mimicking atrial myxoma, potentially leading to a delay in
anticoagulation therapy. In another case report, biatrial in-
tracardiac masses were detected by three-dimensional
TEE in an 80-year-old woman with heart failure, mitral
valve repair, dual chamber permanent pacemaker implant-
ation, and AF. Although direct pathological specimens
were not obtained, the reduction in the size of both
masses after intensive anticoagulation treatment raises the
strong possibility that both masses were thrombi [15].
This case report highlighted the facts that anticoagulation
is a feasible treatment in regressing thrombi when surgery
is relatively contraindicated in an older patient with
comorbidities.
TEE is superior to TTE in delineating and characteriz-
ing cardiac masses [2]. CMR provides high spatial reso-
lution images, improves tissue characterization and is
complementary to echocardiography in the assessment
of cardiac masses [3]. Common CMR sequences are cine
image, T1-weighted and T2-weighted spin echo, contrast
first pass perfusion, and standard delay enhancement.
However, tumors and chronic organized thrombi cannot
be distinguished from one another using the morph-
ology, motility, and enhancement patterns by CMR. A
pattern of hyperintensity/isointensity (compared with
normal myocardium) with short T1, and hypointensity
with long T1, was very frequent in thrombi, rare in
tumors, and had the highest accuracy for the differenti-
ation of both entities [4]. In addition to conventional im-
aging studies, the assessment of vascularity either by
myocardial perfusion contrast echocardiography [16] or
cardiac catheterization may assist in the differentiation
of thrombi and other type of cardiac tumors. Neverthe-
less, in a few instances, the final diagnosis of cardiac
masses can only be made by obtaining a pathological spe-
cimen after surgical resection of cardiac masses [5–7, 12].
For our patient, the nature of biatrial mass was not
specified by histology because he declined surgery. The
presence of MS, AF, SEC and dilated LA indicated a diag-
nosis of thrombi. Our case is unusual because the final
diagnosis was affirmed by empirical anticoagulation based
on clinical judgment and noninvasive characterization of
biatrial mass. A reported case of left atrial thrombus with
a stalk showed that a trial of anticoagulation was beneficial
in regressing the cardiac mass particularly when the differ-
ential diagnosis was difficult and thrombus was a possibil-
ity [6]. There were also cases that reported successful
regressions of the thrombus with anticoagulation without
the need for surgical thrombectomy [15, 17, 18]. Regres-
sion of thrombus using warfarin has been studied in
patients with MS and left atrial thrombus detected prior
to percutaneous transvenous mitral commissurotomy.
Among 219 patients following 6 months of warfarin (INR
2 to 3) therapy, 24.2 % of patients were found to have
complete resolution of thrombus and 75.8 % of patients
were found to have partial resolution of thrombus, and a
higher INR (at least 2.5) predicted thrombus resolution
[19]. For our patient, the regression of his cardiac masses








Fig. 3 Outcome after long-term anticoagulation therapy. The left atrial thrombus is completely resolved as viewed from parasternal long axis (a)
and apical four chamber view (b) in the left atrium. A residual right atrial thrombus (notched arrow) is still visible in the right atrium (b). LA left
atrium, LV left ventricle, RA right atrium, RV right ventricle
Table 1 Biatrial mass with mitral stenosis
Author Year Age/Sex Presentation Atrial fibrillation Diagnosis Treatment
Ibrahim et al. [11] 2008 51/male Right hemiparesis – Myxoma Alteplase administered intravenously + tumor excision
Tasdemir et al. [10] 2008 58/female Left foot pain + Thrombi Thrombectomy + MV surgery
Tsubokawa et al. [9] 2010 77/male Dyspnea + Thrombi Thrombectomy + MV surgery
Khanna et al. [8] 2015 40/female Dyspnea + Thrombi Thrombectomy + MV surgery
MV mitral valve, (+) presence, (–) absence
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warfarin, casting doubt on the true identity of the biatrial
mass. We suspect the main contributing factor towards
the lack of thrombi regression was inadequate anticoagu-
lation owing to his lack of compliance. For this reason,
compliance to anticoagulation therapy was pivotal in
thrombi regression, and it took 5 years to visualize the
resolution of biatrial thrombi. Although a thorough at-
tempt had been made, we could not convince our patient
to agree to surgery. We believe that early mitral valve
surgery and thrombectomy is beneficial in preventing
thromboembolism.
Conclusions
Noninvasive characterization of cardiac mass is essential
in clarifying the diagnosis and directing treatment strat-
egy. Anticoagulation is a feasible treatment when the
clinical assessment, risk factors, and imaging findings in-
dicate a diagnosis of thrombi. After prolonged anticoa-
gulation therapy, complete resolution of biatrial thrombi
was achievable in our case.
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